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420a Tuesday, March 8, 2011receptor aggregates that represent the functional signaling complex. Here, using
a combination of receptor mutagenesis, experiments in living cells (including
FRET), and experiments with purified peptides we report receptor oligomeriza-
tion driven through both covalent and non-covalent interactions in membrane-
proximal regions of the receptor. These results represent the first findings that
pre-ligand receptor oligomerization and signal propagation into the cell may
be driven in part through receptor interactions within and near the membrane.
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A Similar Motif Shared by HIV-1 gp41 and TCRA Trans-Membrane Do-
mains Exploited by the HIV Virus to Modulate T-Cell Proliferation
Yechiel Shai, Tomer Cohen, Shmuel Jaffe Cohen, Niv Antonovsky,
Irun R. Cohen.
The transmembrane domains (TMDs) of the T-cell receptor (TCR) play an im-
portant role in the assembly of the receptor complex. Previous studies have
shown that the fusion peptide (FP) of HIV-1 inhibits T-cell activation and by
that suppress the immune response against the virus. FP gains this activity by
specifically binding to the TMD of TCRa and interfering with the assembly
of the TCR complex We utilized in-silico testing of a TMD sequence library
derived from virus protein sequences, and pin-pointed a nine amino-acid motif
shared by a group of different viruses; this motif resembles the transmembrane
domain of the a-subunit of the T-cell receptor (TCRa). The highest similarity
was found within SIV and HIV glycoprotein 41 TMD (gp41 TMD). Previous
studies have shown that stable interactions between TCRa and CD3 are local-
ized to this nine amino acid motif within TCRa, and a peptide derived from it
interfered and intervened in the TCR function when added exogenously. By
combining biophysical and biochemical approaches we found that the gp41
TMD peptide co-localizes with CD3 within the TCR complex and inhibits
T-cell proliferation in vitro. We also found that the inhibitory mechanism of
gp41 TMD differs from that of FP. Disassociated from HIV, the gp41 TMD
molecule provides a novel mechanism for down regulating undesirable re-
sponses and might be be used as an immunotherapeutic tool.
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Cooperativity in the Binding of Agonists to Reconstituted Tetramers of the
M2 Muscarinic Receptor
Dar’ya S. Redka, Heiko Heerklotz, James W. Wells.
G protein-coupled receptors display a dispersion of affinities in the binding of
agonists, the breadth of which is a measure of efficacy. The implied heteroge-
neity commonly is thought to be induced by the G protein in an otherwise ho-
mogeneous population of receptors. In some early studies, however, purified
M2 muscarinic receptor also revealed heterogeneity under some conditions.
We have shown that M2 receptors extracted from Sf9 cells can be purified as
monomers devoid of G protein and reconstituted almost exclusively as tetra-
mers in phospholipid vesicles (POPC/POPS/cholesterol), as indicated by
cross-linking. Monomers in solution appeared homogeneous, as indicated by
Hill coefficients near 1 for the inhibitory effect of agonists on binding of the
antagonist N-[3H]methylscopolamine; in contrast, reconstituted tetramers ap-
peared heterogeneous (nH < 1) in a manner that correlated with efficacy as re-
ported for GTPase activity (p = 0.013). It follows that efficacy is intrinsic to the
receptor in its tetrameric state.
To examine whether heterogeneity arises from pre-existing asymmetry within
the tetramer or is induced through cooperativity between ligands, the inhibitory
effect of two agonists (oxotremorine-M, arecoline) and two antagonists (N-
methylscopolamine, atropine) was measured at two concentrations of N-[3H]
methylscopolamine. The data were analyzed simultaneously in terms of four
dissimilar and non-interacting sites (i.e., asymmetry) and four interacting sites
(i.e., cooperativity). The radioligand was assumed to label only two of the four
sites, because the capacity for N-[3H]methylscopolamine doubled upon disso-
lution of reconstituted receptors in digitonin; one-half of the reconstituted sites
therefore were inaccessible to the radioligand. Whereas the data could not be
described in terms intrinsic asymmetry alone, the fit improved markedly
upon the introduction of cooperative interactions (p< 0.00001). Efficacy there-
fore appears to arise at least in part from cooperativity within the tetramer.
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Mechanistic Insights into Reversal of Pulmonary Hypertension by Estro-
gen Therapy
Soban Umar, Humann Matori, Andrea Iorga, Michelle Afkhami,
Jingyuan Li, Federica Maltese, Mansoureh Eghbali.
Severe pulmonary hypertension(PH) leads to right-ventricular failure(RVF) and
death. Estrogen(E2) pretreatment has been shown to attenuate development of
PH. Here, we tested the hypothesis that E2 may also reverse advanced PH and
investigated its underlyingmechanisms.Male rats were treated withmonocrota-
line(MCT,60 mg/kg) to induce PH(n=36). At day-21 when PH had established,
one group was euthanized(PH, n=8), and 5 other groups for 10 days receivedeither i) E2 (0.017 mg/day, n=12) ii) E2 plus angiogenesis inhibitor TNP-470
(1.2 mg/day, n=3) iii) ERb-agonist DPN(0.34 mg/day, n=3) iv) ERa-agonist
PPT(0.34mg/day, n=3) or v) left untreated(RVF, n=7). Saline-treated rats served
as controls(CTRL, n=6). Echocardiography, cardiac catheterization, RT-PCR,
Western-blot and immunocytochemistry were performed. MCT-group devel-
oped severe PH at day21 as RV-pressure (RVP) increased from 3152 in
CTRL to 6952 mmHg. E2 reversed PH(RVP=3852mmHg, P<0.05) com-
pletely resulting in full recovery. Interestingly, E2 failed to rescue PH when ap-
plied together with TNP. VGEF protein in RV and lungs was reduced
significantly ~5fold in PH and E2 increased VEGF significantly ~10 fold. Re-
duced RV capillary-density in PH was restored fully by E2. E2 reduced cardio-
pulmonary inflammation as IL-6 transcript upregulation in PH(~22 fold in lung,
~7 folds in RV) was partially reversed by E2. Lungs showed 4-fold increase in
ED1-inflammatory cells in PH and E2 reversed this increase. Lung ERb-
transcripts, but not ERa, were significantly reduced 6-fold in PH and were re-
stored by E2. ERb protein in lung and RV was also significantly reduced ~2
fold in PH and E2 restored ERb. ERb agonist DPN was as effective as E2 to res-
cue PH (RVP=3451 mmHg), whereas PPT was not as effective. In conclusion,
E2 rescues PH by stimulating cardiopulmonary neoangiogenesis and suppress-
ing inflammation mainly via ERb.
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Expression and Spectroscopic Characterization of Melanopsin and Squid
Rhodopsin
Nazhat Shirzad-Wasei, Erica Saint Clair, John I. Ogren, Christie Stanzel,
Javier Navarro, Willem J. deGrip, Kenneth J. Rothschild.
Melanopsin, found in intrinsically photosensitive retinal ganglion cells, drives
circadian rhythm and pupillary response. A variety of studies indicate that mel-
anopsin shares many properties with invertebrate rhodopsin such as found in
the eyes of squid including activation by an initial photon absorption and regen-
eration to the original state with a second red-shifted photon. We report the ex-
pression and initial spectroscopic characterization of recombinant expressed
melanopsin. Mouse melanopsin, carrying a C-terminal deca-his-tag, was ex-
pressed in Sf9 insect cells, using recombinant baculovrius. Good expression
levels of intact melanopsin protein were achieved (2-4 mg/l). To regenerate
the active photopigment 11-cis retinal was added. However, solubilization ef-
ficiency was quite low for most detergents. Best results were obtained with do-
decylphosphocholine (DPC). Efficient single-step purification was achieved
with affinity chromatography over immobilized Ni-2þ ions. So far only a small
percentage of the purified melanopsin was photoactive, showing a maximum
absorbance at 480-500 nm. Preliminary low-temperature FTIR difference and
resonance Raman spectroscopic measurements are reported for melanopsin
and squid rhodopsin in order to compare structural features and conformational
changes upon light activation including retinal isomerization and protein back-
bone changes. Supported by a grants from the NIH-NEI to KJR and from
NWO-CW to WJdG.
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FGF13 is a Regulator of the Cardiac Voltage-Gated Sodium Channel
Nav1.5
Chuan Wang, Jessica A. Hennessey, Robert D. Kirkton, Chaojian Wang,
Victoria Bryson, Paul B. Rosenberg, Nenad Bursac, Geoffrey S. Pitt.
The four members of the intracellular Fibroblast Growth Factor (iFGF) subfam-
ily, FGF11-14, regulate voltage-gated sodium (Nav) channels. Amissense muta-
tion in FGF14 causes spinocerebellar ataxia 27, thought to be due to Nav channel
dysfunction. iFGFs are expressed in the heart, but whether they regulate cardiac
Nav channels is not known. Using quantitative real-time RT-PCR, we identified
that FGF13 isoforms are the dominant iFGFs in adult mouse heart. Using whole
cell patch-clamp configuration, we determined a functional link between FGF13
and Nav1.5. We found that the FGF13 isoforms, FGF13S, FGF13U, and
FGF13VY differentially modulate Nav1.5 current density when transiently co-
expressed in HEK293 cells. Steady-state activation was not altered. In contrast,
steady-state availability was significantly shifted towards the depolarizing direc-
tion by each of the FGF13 isoforms.Most strikingly, FGF13S induced a dramatic
slowing of recovery from inactivation. Co-immunoprecipitation showed that
FGF13 interacted with Nav1.5 in cardiomyocytes. Using a pull down assay,
we found that FGF13 directly interacted with C-terminus of Nav1.5. Immunos-
taining showed that FGF13 co-localized with Nav1.5 on sarcolemma. Some
FGF13 is present in subcellular regions devoid of Nav1.5, suggesting other roles
than sodium channel modulation. FGF13 knockdown by adenoviral infection
with shRNA in adult mice cardiomyocytes affected sodium current density and
steady-state availability. FGF13 knockdown in a neonatal rat cardiomyocyte
monolayer reduced cardiac impulse conduction and the velocity of the action
